Interestingly, inflammatory markers including MCP-1 and progranulin were not significantly modified in the female patient cohort (independent of ethnicity), despite the potential of these markers as early detectors in the diagnosis of AD. This evidence concerns the gene CCL2 and Alzheimer disease.